DrugsControl Media Services

News Detail

Mankind Pharma reduces price of its heart failure drug by 70 percent (26-01-2023)

Mumbai, 25 Jan 2023: As domestic pharma players race to launch the generic version of Novartis’ blockbuster heart failure drug after its patent expiry, Mankind Pharma reduced the price of its drug, NEPTAZ, by 70 percent in India.


The patent of Novarti......
View Details

Source : The Financial Express
Mankind pharma heart failure drug NEPTAZ Novartis vymada health news pharma news

Related News